Simplified rules-based tool to facilitate the application of up-to-date management recommendations in cardio-oncology
-
Published:2023-10-27
Issue:1
Volume:9
Page:
-
ISSN:2057-3804
-
Container-title:Cardio-Oncology
-
language:en
-
Short-container-title:Cardio-Oncology
Author:
Brown Sherry-Ann,Hamid Abdulaziz,Pederson Erin,BS Allen Hanna,Maddula Ragasnehith,Goodman Rachel,Lamberg Morgan,Caraballo Pedro,Noseworthy Peter,Lukan Opeoluwa,Echefu Gift,Berman Generika,Choudhuri Indrajit,
Abstract
Abstract
Background
Millions of cancer survivors are at risk of cardiovascular diseases, a leading cause of morbidity and mortality. Tools to potentially facilitate implementation of cardiology guidelines, consensus recommendations, and scientific statements to prevent atherosclerotic cardiovascular disease (ASCVD) and other cardiovascular diseases are limited. Thus, inadequate utilization of cardiovascular medications and imaging is widespread, including significantly lower rates of statin use among cancer survivors for whom statin therapy is indicated.
Methods
In this methodological study, we leveraged published guidelines documents to create a rules-based tool to include guidelines, expert consensus, and medical society scientific statements relevant to point of care cardiovascular disease prevention in the cardiovascular care of cancer survivors. Any overlap, redundancy, or ambiguous recommendations were identified and eliminated across all converted sources of knowledge. The integrity of the tool was assessed with use case examples and review of subsequent care suggestions.
Results
An initial selection of 10 guidelines, expert consensus, and medical society scientific statements was made for this study. Then 7 were kept owing to overlap and revisions in society recommendations over recent years. Extensive formulae were employed to translate the recommendations of 7 selected guidelines into rules and proposed action measures. Patient suitability and care suggestions were assessed for several use case examples.
Conclusion
A simple rules-based application was designed to provide a potential format to deliver critical cardiovascular disease best-practice prevention recommendations at the point of care for cancer survivors. A version of this tool may potentially facilitate implementing these guidelines across clinics, payers, and health systems for preventing cardiovascular diseases in cancer survivors.
Trial Registration
ClinicalTrials.Gov Identifier: NCT05377320.
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Oncology
Reference58 articles.
1. Chang HM, Moudgil R, Scarabelli T, Okwuosa TM, Yeh ETH. Cardiovascular Complications of Cancer Therapy: best Practices in diagnosis, Prevention, and management: part 1. J Am Coll Cardiol. 2017;70(20):2536–51. 2. Chang HM, Okwuosa TM, Scarabelli T, Moudgil R, Yeh ETH. Cardiovascular Complications of Cancer Therapy: best Practices in diagnosis, Prevention, and management: part 2. J Am Coll Cardiol. 2017;70(20):2552–65. 3. Noone AMHN, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review, 1975–2015, based on November 2017 SEER data submission, posted to the SEER web site, April 2018. Bethesda: National Cancer Institute; 2018. Available from: https://seer.cancer.gov/csr/1975_2015/. 4. Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85. 5. Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, et al. Cardiovascular Disease and breast Cancer: where these entities Intersect: A Scientific Statement from the American Heart Association. Circulation. 2018;137(8):e30–66.
|
|